Our Product Portfolio Groups
Viramal has a sizeable pipeline of women’s health products in various phases of development that are expected to launch over the next several years. Spanning treatments for fertility, menopausal hormone therapy, contraception and sexual health, our products utilize a novel delivery platform that overcomes significant side effects in existing women’s health products and also addresses unmet therapeutic areas.
Among the advantages of Viramal’s proprietary and patent protected delivery platforms are improved safety, efficacy and patient acceptability, reduced side effects, and both localized and systemic targeted delivery to optimize drug concentration.
We are currently advancing the below pipeline of prescription and non-prescription drugs ranging from pre-clinical through to pivotal Phase III studies:
By developing women’s health products with superior safety and efficacy outcomes, we expect to expand the market for women’s health and gain market share with our improved formulations and products. In addition, we are creating new markets through innovative products that leverage Viramal’s technology platform.
With an established track record in developing market-leading women’s health products and a robust product pipeline that leverages our novel delivery platform, we are strongly positioned for continued success.